Clinical trials
Active, not recruiting Phase 2 trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 14 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Swiss Cancer Institute | 6 |
| Merck Sharp & Dohme LLC | 4 |
| Amgen | 3 |
| Hoffmann-La Roche | 3 |
| International Extranodal Lymphoma Study Group (IELSG) | 3 |
| University of Zurich | 3 |
| AbbVie | 2 |
| ETOP IBCSG Partners Foundation | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasms | 4 |
| Small Cell Lung Carcinoma | 4 |
| Colitis, Ulcerative | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Neoplasm Metastasis | 3 |
| Adenocarcinoma | 2 |
| Digestive System Diseases | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lung Diseases, Interstitial | 2 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.